Literature DB >> 10070803

Internal absorbed dose estimation by a TLD method for 18F-FDG and comparison with the dose estimates from whole body PET.

H M Deloar1, T Fujiwara, M Shidahara, T Nakamura, A Yamadera, M Itoh.   

Abstract

The thermoluminescent dosimeter (TLD) method has been proposed as a useful tool for estimating internal radiation absorbed dose in nuclear medicine. An efficient approach to verify the accuracy of the TLD method has been performed in this study. Under the standard protocol for 2-[F-18]fluoro-2-deoxy-D-glucose (18F-FDG), whole body PET experiments and simultaneous body surface dose measurements by TLDs were performed on six normal volunteers. By using the body surface dose measured with TLDs, the cumulated activities of nine source organs were estimated with a mathematical unfolding technique for three different initial guesses. The accuracy of the results obtained by the TLD method was investigated by comparison with the actual cumulated activity of the same source organs measured by whole body PET. The cumulated activities of the source organs obtained by the TLD method and whole body PET show a significant correlation (correlation coefficient, r > 0.98, level of confidence, p < 0.001) with each other. The mean effective doses in this study are 3.2 x 10(-2) mSv MBq(-1) obtained from the TLD method and 2.9 x 10(-2) mSv MBq(-1) obtained from the whole body PET. Good agreement between the results of the TLD method and whole body PET was observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070803     DOI: 10.1088/0031-9155/44/2/021

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  6 in total

1.  Error evaluation of the D-shuttle dosimeter technique in positron emission tomography study.

Authors:  Md Shahidul Islam; Shoichi Watanuki; Manabu Tashiro; Hiroshi Watabe
Journal:  Radiol Phys Technol       Date:  2019-08-16

2.  Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.

Authors:  Zsolt Szabo; Esther Mena; Steven P Rowe; Donika Plyku; Rosa Nidal; Mario A Eisenberger; Emmanuel S Antonarakis; Hong Fan; Robert F Dannals; Ying Chen; Ronnie C Mease; Melin Vranesic; Akrita Bhatnagar; George Sgouros; Steve Y Cho; Martin G Pomper
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

3.  Radiation exposure during transmission measurements: comparison between CT- and germanium-based techniques with a current PET scanner.

Authors:  Tung-Hsin Wu; Yung-Hui Huang; Jason J S Lee; Shih-Yuan Wang; Su-Cheng Wang; Cheng-Tau Su; Liang-Kung Chen; Tieh-Chi Chu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-08       Impact factor: 9.236

Review 4.  Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review.

Authors:  Uta Eberlein; Jörn Hendrik Bröer; Charlot Vandevoorde; Paula Santos; Manuel Bardiès; Klaus Bacher; Dietmar Nosske; Michael Lassmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-30       Impact factor: 9.236

5.  First-in-human uPAR PET: Imaging of Cancer Aggressiveness.

Authors:  Morten Persson; Dorthe Skovgaard; Malene Brandt-Larsen; Camilla Christensen; Jacob Madsen; Carsten H Nielsen; Tine Thurison; Thomas Levin Klausen; Søren Holm; Annika Loft; Anne Kiil Berthelsen; Michael Ploug; Helle Pappot; Klaus Brasso; Niels Kroman; Liselotte Højgaard; Andreas Kjaer
Journal:  Theranostics       Date:  2015-09-13       Impact factor: 11.556

6.  Estimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocol.

Authors:  Aruna Kaushik; Abhinav Jaimini; Madhavi Tripathi; Maria D'Souza; Rajnish Sharma; Anupam Mondal; Anil K Mishra; Bilikere S Dwarakanath
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.